Trupanion Inc focuses on pet insurance growth as a niche player in the US market
Trupanion Inc. specializes in pet health insurance for dogs and cats in North America, positioning itself as a niche player in the growing US market. The company operates on a recurring premium income model, covering veterinary costs for unexpected illnesses and injuries, and differentiates itself through high reimbursement percentages and integration with veterinary clinics. Trupanion's stock performance is linked to the adoption of pet insurance, underwriting efficiency, and expense management, offering investors focused exposure to the pet insurance landscape.
TRUP Financials: Revenue Breakdown, Margins & Competitor Comparison
This article analyzes Trupanion Inc.'s (TRUP) financial performance, focusing on its revenue breakdown, profitability margins, and comparison with competitors. The company primarily generates revenue from its Subscription business (70.2% of total sales), maintaining a gross margin of 15.05%, an operating margin of 1.24%, and a net margin of 1.27%. With a market capitalization of $1.17B, TRUP is benchmarked against BOW and DGICA within the Life & Health Insurance industry.
Trupanion stock reflects a thin news tape. The insurer stays tied to pet care demand.
Trupanion Inc. (ISIN US89832Q1094) operates a subscription-based pet insurance model focusing on veterinary coverage for cats and dogs. The company's performance is driven by pet owner demand, claims behavior, and veterinary cost trends, emphasizing policy renewals and underwriting discipline. Investors monitor subscriber growth, margins, and claims costs, with the company's official investor materials providing the most reliable operational updates.
Trupanion, Inc. Financial Disclosures & Filings
This page provides a comprehensive list of Trupanion, Inc.'s financial disclosures and regulatory filings, including earnings reports, annual reports, quarterly reports, and investor presentation transcripts. The documents cover various fiscal years, offering insights into company performance, strategy, growth, and investor communications.
Trupanion COO John Gallagher sells $10,925 in company stock By Investing.com
Trupanion COO John Gallagher sold 431 shares of company stock worth $10,925 on June 29, 2026, as part of a pre-established 10b5-1 trading plan for financial diversification. This transaction follows a 30% decline in Trupanion's shares over the past six months, though InvestingPro analysis suggests the stock is currently undervalued. The company recently reported better-than-expected Q1 2026 earnings, yet analysts have adjusted price targets due to concerns about product strategy and declining market share.
Trupanion COO John Gallagher sells $10,925 in company stock
Trupanion's COO, John Gallagher, sold 431 shares of company stock worth $10,925 on June 29, 2026, as part of a pre-established Rule 10b5-1 trading plan for financial diversification. This transaction occurred amidst a 30% decline in Trupanion shares over the last six months, despite analysis suggesting the stock is undervalued. Gallagher now directly holds 32,634 shares of the company.
Trupanion COO John Gallagher sells $10,925 in company stock
Trupanion's COO, John R. Gallagher, sold 431 shares of company stock worth $10,925 on June 29, 2026, as part of a pre-arranged Rule 10b5-1 trading plan for financial diversification. This transaction comes amidst a 30% decline in Trupanion's shares over the past six months, trading significantly below its 52-week high. The company recently reported better-than-expected Q1 2026 earnings, though analysts have adjusted price targets due to ongoing market challenges and concerns about its product strategy and declining market share.
Trupanion (TRUP) COO executes Rule 10b5-1 sale of 431 shares at $25.35
Trupanion's Chief Operating Officer, John R. Gallagher, sold 431 shares of common stock at $25.35 per share through a pre-arranged Rule 10b5-1 trading plan. After this transaction, his direct holdings in the company amount to 32,634 shares. The sale, valued at approximately $10,926, was made on June 29, 2026.
Trupanion (TRUP) Fireside Chat Puts Its Undervalued Narrative Back In Focus
Trupanion (TRUP) recently participated in a Piper Sandler fireside chat, addressing investors after a significant share price decline. Despite challenges like negative return on equity over five years, the stock is currently seen as undervalued by some analysts at $24.77 against a $39.75 price target, driven by assumptions of improved underwriting and cash flow. However, divergent views exist, with its high P/E ratio of 41.9x suggesting it looks expensive compared to industry averages and raising questions about the optimism behind analyst targets.
Trupanion (TRUP) Fireside Chat Puts Its Undervalued Narrative Back In Focus
A recent fireside chat hosted by Piper Sandler has refocused attention on Trupanion (TRUP) after a significant stock price decline, highlighting its undervalued narrative. Despite past negative returns on equity, the company is projected to be 38% undervalued based on a fair value of $39.75, driven by anticipated improvements in underwriting, higher lifetime value pets, and optimized customer acquisition. However, its high P/E ratio of 41.9x, compared to an industry average of 11.8x, raises concerns about its current valuation relative to earnings.
Trupanion, Inc. Financial Disclosures & Filings
This page provides an extensive list of Trupanion, Inc.'s financial disclosures and filings, including earnings reports, investor presentations, and conference transcripts ranging from 2023 to 2026. These documents offer insights into the company's performance, strategy, growth initiatives, and financial outlook, supporting informed investment decisions. Each entry includes links to specific reports like 10-Q, 8-K, 10-K, and call/event transcripts.
Trupanion, Inc. Financial Disclosures & Filings
This article provides an organized list of Trupanion, Inc.'s financial disclosures and regulatory filings, including earnings reports, investor presentations, and conference transcripts. It covers a period from 2023 to Q1 FY2026, highlighting key financial performance indicators, growth strategies, and market outlooks. The documents offer insights into the company's operational performance, strategic initiatives, and investor communications.
Price to earnings forward of Trupanion, Inc. – NASDAQ:TRUP
This article displays the "Price to earnings forward" value for Trupanion, Inc. (NASDAQ: TRUP). It indicates that the period value and change are presented, noting that the data is made by humans and available in English.
Trupanion, Inc. Actuals & Estimates (BX:TPW)
This article provides an overview of Trupanion, Inc. (TPW) including its financial actuals and estimates, analyst forecasts, and company details. It highlights recent earnings, revenue, and net income, alongside its employee count and dividend policy. The article also addresses frequently asked questions about buying TPW stock and tracking its financial reports.
Stifel reiterates Trupanion stock rating at Hold with $28 target
Stifel has reiterated a Hold rating on Trupanion (NASDAQ:TRUP) with a $28 price target, citing concerns over the pet insurance company's declining market share and pricing strategy. Despite these challenges, InvestingPro analysis suggests the stock is undervalued with a fair value of $30.94, and analysts anticipate profitability this year. Trupanion recently surpassed Q1 2026 earnings and revenue expectations, although BofA Securities lowered its price target to $52 while maintaining a Buy rating.
Price to sales forward of Trupanion, Inc. – FWB:TPW
This article provides financial information for Trupanion, Inc. (FWB:TPW) including its price to sales forward. It indicates that the
Stifel reiterates Trupanion stock rating at Hold with $28 target By Investing.com
Stifel reiterated a Hold rating on Trupanion (NASDAQ:TRUP) with a $28 price target, noting the company's continuous decline in North American pet insurance market share and the slowdown in market growth. Despite these challenges, Trupanion plans to broaden its product offerings, and InvestingPro analysis suggests the stock is undervalued with analysts predicting profitability this year.
Price to sales forward of Trupanion, Inc. – NASDAQ:TRUP
This article provides financial information for Trupanion, Inc. (NASDAQ: TRUP), specifically focusing on its "Price to sales forward" metric. It appears to be an entry on a financial data platform like TradingView, offering an overview of the company's financials for investors.
Stifel reiterates Trupanion stock rating at Hold with $28 target By Investing.com
Stifel reiterated a Hold rating on Trupanion (NASDAQ:TRUP) with a $28 price target, noting the pet insurance company's declining North American market share and slowing market growth due to rising premiums. Despite these challenges, InvestingPro analysis indicates the stock is undervalued with a Fair Value of $30.94, and analysts predict profitability for the company this year, supporting its recent strategic pivot to broaden product offerings.
Price to book forward of Trupanion, Inc. – FWB:TPW
This article provides financial information for Trupanion, Inc. (FWB:TPW), specifically focusing on its price-to-book forward ratio. The content appears to be a stub or a data placeholder from TradingView, offering a very limited amount of financial data apart from the company name and stock exchange. Most of the page consists of navigation, product, and community links.
Stifel Maintains Trupanion(TRUP.US) With Hold Rating, Maintains Target Price $28
Stifel has reiterated its Hold rating for Trupanion (TRUP.US), an animal health insurance provider. The firm also maintained its target price for the company at $28. This suggests Stifel believes Trupanion's stock will perform in line with the broader market and sees its fair value at the current target price.
Trupanion, Inc. Actuals & Estimates (NASDAQ:TRUP)
This article provides an overview of Trupanion, Inc. (NASDAQ:TRUP) stock, including its current price, historical performance, analyst forecasts, and various financial metrics. It highlights the company's market capitalization, recent earnings, revenue, and upcoming earnings date. The article also touches on stock volatility, dividend policy, employee count, and guidance on how to purchase TRUP stocks.
TRUP Forecast — Price Target — Prediction for 2027
This article provides a detailed forecast for Trupanion, Inc. (TRUP) stock, including analyst price targets, past performance, and key financial metrics. It highlights TRUP's current stock price, volatility, market capitalization, and upcoming earnings report, aiming to inform potential investors about its market standing and future outlook.
Price to earnings forward of Trupanion, Inc. – FWB:TPW
This article provides the "Price to earnings forward" value for Trupanion, Inc. (FWB:TPW). It indicates that the market is closed, and there were no trades. The information is presented within the context of financial data provided by ICE Data Services and FactSet.
Trupanion to Participate in Virtual Fireside Chat with Piper Sandler
Trupanion, a leader in pet medical insurance, announced that CEO Margi Tooth will participate in a virtual fireside chat with Piper Sandler on June 30, 2026, at 10:00 a.m. PT. Interested parties can contact their Piper Sandler Sales Representative for registration, and a replay will be available on Trupanion's Investor Relations website. The company provides medical insurance for over 1.1 million pets across North America and parts of Europe, offering unlimited payouts for eligible expenses.
Thrive Pet Healthcare Expands Pet Insurance Access Through Pumpkin and Trupanion to Help Pet Owners Plan for Veterinary Care Costs
Thrive Pet Healthcare has announced a partnership with Pumpkin and Trupanion to expand pet insurance options for pet owners, aiming to help manage veterinary care costs. This initiative builds on existing financial solutions like Thrive Plus memberships and CareCredit, allowing pet owners to plan for preventive, emergency, and specialty care. The collaboration seeks to reduce financial uncertainty and ensure pets receive timely, high-quality treatment.
Trupanion to Participate in Virtual Fireside Chat with Piper Sandler
Trupanion (Nasdaq: TRUP) announced that its CEO and President, Margi Tooth, will engage in a virtual fireside chat with Piper Sandler on Tuesday, June 30, 2026, at 10:00 a.m. PT. Interested parties can contact their Piper Sandler Sales Representative for details, and a webcast replay will be available on Trupanion's Investor Relations website. The company is a leading provider of medical insurance for cats and dogs with over 1.1 million enrolled pets across North America and parts of Europe.
How Record Margins and Veterinary Ties At Trupanion (TRUP) Have Changed Its Investment Story
Trupanion reported strong Q1 2026 results with record subscription margins and high subscriber retention, reinforcing its investment narrative around efficiency and profitability. The company also highlighted its strong ties with the veterinary community through its Veterinary Appreciation Day awards. However, concerns remain about growth increasingly depending on price increases rather than new pet additions, and potentially slower gross pet additions despite improving margins.
How Record Margins and Veterinary Ties At Trupanion (TRUP) Have Changed Its Investment Story
Trupanion reported strong first-quarter 2026 results with record subscription margins and high subscriber retention, reinforcing its investment narrative focusing on efficiency and profitability. The company also highlighted its close ties to the veterinary community through its Veterinary Appreciation Day awards. However, investors are cautioned to monitor slower gross pet additions and increased reliance on price increases for growth.
Trupanion Announces Winners of the 2026 Veterinary Appreciation Day® Awards
Trupanion announced the winners of its 2026 Veterinary Appreciation Day Awards, recognizing 12 veterinary professionals and teams across North America for their exceptional dedication and compassion. This year marked the largest campaign in Trupanion history, with nearly 2,000 nominations and over 86,000 public votes. The awards highlight individuals and teams who make a significant difference in the lives of pets and their families, with examples including compassionate care from Dr. Ashley McCaughan and the life-saving efforts of the Metropolitan Veterinary Specialists and Emergency Service team.
Trupanion Shareholders Back Board, Auditor and Pay Plans
Trupanion shareholders recently re-elected all nine directors to the board, ratified Ernst & Young LLP as the independent auditor for 2026, and approved the executive compensation plan for 2025. These decisions demonstrate strong shareholder support for the company's governance and financial practices. Despite a "Neutral" rating from TipRanks' AI Analyst, citing improving financial performance and a constructive earnings outlook, the stock faces challenges including a bearish technical trend and high valuation.
Trupanion Shareholders Back Board, Auditor and Pay Plans
During its 2026 Annual Meeting, Trupanion shareholders re-elected all nine directors to the board, ratified Ernst & Young LLP as the independent auditor for the fiscal year ending December 31, 2026, and approved the compensation program for its executive officers. TipRanks' AI Analyst, Spark, rates TRUP as Neutral, citing improving financial performance and a constructive earnings outlook, but also notes bearish technical trends and a high valuation. Trupanion provides medical insurance for cats and dogs and has a current market cap of $1.03 billion.
Trupanion (NASDAQ: TRUP) investors back board slate, auditor and 2025 pay
Trupanion, Inc. (NASDAQ: TRUP) announced the results of its 2026 Annual Meeting of stockholders. Shareholders elected all nine director nominees to the board, ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, and approved the advisory vote on named executive officer compensation for 2025. All proposals received overwhelming shareholder support.
Trupanion (TRUP) Stock Valuation Check After Recent Momentum And Underperformance
Trupanion (TRUP) has seen recent positive momentum, with its stock up 7.5% over the past week, yet it remains significantly down year-to-date. Analysts project a fair value of $39.75, suggesting the stock is currently undervalued compared to its last close of $23.65, based on improved underwriting and growth strategies. However, its high P/E ratio of 40x, compared to an industry average of 11.3x, indicates considerable optimism may already be priced in, raising concerns about potential overvaluation despite the positive narrative.
Meet the New CEOs named in 2024: Margi Tooth
This article introduces Margi Tooth, the Chief Marketing Officer for Trupanion, as one of the leaders named CEO in 2024. It is part of a larger series by the Puget Sound Business Journal highlighting new CEOs. Other individuals mentioned in the series include Rachele Turnbull of Clark Construction, Jeremy Wacksman of Zillow Group Inc., Cynthia Williams of Funko Inc., and Rick Bergman of Kymeta.
Trupanion EVP Steve Weinrauch sells $146,828 in company stock By Investing.com
Trupanion EVP Steve Weinrauch sold $146,828 worth of company stock on June 5, 2026, comprising 6,674 shares at an average price of $22.00. On the same day, he acquired 8,500 shares for $131,410 by exercising stock options, bringing his direct holdings to 78,062 shares. These transactions occur as Trupanion's stock trades near its 52-week low, and despite recent positive earnings, analysts from BofA Securities and Stifel have lowered price targets due to margin and product strategy concerns.
Options Exercise: Steve Weinrauch At Trupanion Realizes $57K
Steve Weinrauch, EVP at Trupanion, exercised options for 8,500 shares of TRUP stock at an exercise price of $15.46 per share, realizing $57,035 as the stock traded at $22.17. The article also reviews Trupanion's financial performance, noting positive revenue growth but challenges with debt, gross margin, and EPS, while its valuation metrics are mixed. The importance of insider transactions as part of a broader investment analysis is highlighted.
Trupanion EVP Steve Weinrauch sells $146,828 in company stock
Trupanion EVP Steve Weinrauch sold 6,674 shares of company stock worth $146,828 and simultaneously acquired 8,500 shares for $131,410 through stock option exercises on June 5, 2026. These transactions leave him with a direct holding of 78,062 shares. The insider activity comes as Trupanion's shares trade near their 52-week low, despite the company reporting better-than-expected Q1 2026 earnings, though analysts maintain mixed views due to concerns over margin performance and product strategy.
[Form 4] TRUPANION, INC. Insider Trading Activity
An SEC Form 4 filing for TRUPANION, INC. (TRUP) shows that Steve Weinrauch, EVP, North Am & Vet Strategy, was a net seller of 6,674 shares valued at approximately $147,000. The transactions involved exercising stock options and subsequently selling common stock on June 5, 2026. After these transactions, Weinrauch beneficially owns 78,062 shares of common stock.
Trupanion EVP Steve Weinrauch sells $146,828 in company stock
Trupanion's EVP Steve Weinrauch sold 6,674 shares of company stock for $146,828 and simultaneously acquired 8,500 shares for $131,410 by exercising stock options. These transactions occurred as Trupanion's shares trade near their 52-week low, with InvestingPro analysis indicating the stock is undervalued. The company recently reported better-than-expected Q1 2026 earnings, though analysts have lowered price targets due to margin performance and product strategy concerns.
[144] TRUPANION, INC. SEC Filing
This SEC filing (Form 144) for Trupanion, Inc. (TRUP) concerns a proposed sale of securities. The document details the filer information, issuer information, and specifics about the securities to be sold, including the class (Common), the number of shares (6674), and the aggregate market value ($146,831.34), acquired through a stock option exercise on June 5, 2026. The filing also includes a representation that the filer has no material adverse information not publicly disclosed.
Emily Dreyer, Trupanion’s CRO, sells $219k in stock
Emily Dreyer, Chief Revenue Officer of Trupanion (NASDAQ:TRUP), sold 7,792 shares of company stock for approximately $219,319 on March 4, 2026. This transaction occurred while Trupanion's stock was trading near its 52-week low. Despite the stock's recent decline, InvestingPro analysis indicates that it is undervalued, with analysts forecasting profitability growth for the current year.
Trupanion Chief Operating Officer Sold $78K In Company Stock
Trupanion's Chief Operating Officer, John R Gallagher, recently sold 3,603 shares of company stock, totaling $78,153. This sale occurred while Trupanion shares were trading down 2.61% at $22.0. The article also provides financial details for Trupanion, highlighting its 12.3% revenue growth, challenges with a low gross margin of 16.01%, and a high debt-to-equity ratio of 0.28.
Trupanion COO John Gallagher sells $78,153 of company stock By Investing.com
Trupanion COO John Gallagher sold $78,153 worth of company stock on May 28, 2026, as part of a Rule 10b5-1 trading plan for financial diversification. This transaction occurred while Trupanion's stock was near its 52-week low. Despite the stock's performance, the company recently reported strong Q1 2026 financial results, though analysts have mixed reactions to its future outlook.
Trupanion (TRUP) EVP exercises 1,526 RSUs and corrects prior Form 4
Simon Wheeler, EVP of Trupanion International, exercised 1,526 restricted stock units (RSUs) on February 22, 2026, as part of his equity compensation, which converted into common stock. This filing is an amendment (Form 4/A) to correct clerical errors in previously reported derivative holdings related to an RSU grant from February 27, 2024. The corrected filing clarifies the number of RSUs beneficially owned on November 25, 2025, and February 24, 2026, and indicates that zero RSUs from this specific grant remained after the exercise.
TRUPANION (TRUP) COO logs pre-planned sale of 3,603 shares at about $22
TRUPANION's Chief Operating Officer, John R. Gallagher, executed a pre-planned sale of 3,603 common shares at a weighted average price of $21.6912 per share on May 28, 2026. This transaction was carried out under a Rule 10b5-1 trading plan adopted in August 2025 for financial diversification, meaning the timing was not at his discretion. Following the sale, Gallagher directly holds 33,065 shares of the company.
Trupanion COO John Gallagher sells $78,153 of company stock
Trupanion COO John Gallagher sold 3,603 shares of company stock worth $78,153 on May 28, 2026, as part of a pre-arranged trading plan for financial diversification. This sale occurred while Trupanion's stock was near its 52-week low. Despite the stock's performance, the company recently surpassed Q1 2026 earnings and revenue expectations, though analysts have offered mixed reactions with revised price targets.
Trupanion CFO Fawwad Qureshi sells $137,016 in company stock
Trupanion's CFO Fawwad Qureshi sold 6,177 shares of company stock for $137,016 on May 27, 2026, executed under a pre-arranged Rule 10b5-1 trading plan for financial diversification. This sale occurred while the stock was near its 52-week low, but Qureshi also acquired shares through RSU conversions, with some withheld for tax obligations. Despite the stock sale, Trupanion recently reported strong Q1 2026 earnings, though analysts have adjusted price targets due to concerns about product strategy and margin performance.
Trupanion (TRUP) director Howard Rubin converts 318 RSUs into common stock
Trupanion director Howard E. Rubin converted 318 restricted stock units (RSUs) into common stock on May 22, 2026. These RSUs were part of his equity compensation for serving on the boards of wholly-owned subsidiaries and converted on a one-for-one basis. Following this transaction, Rubin directly holds 232,656 shares of Trupanion common stock, with no open-market purchases or sales reported.
Trupanion (TRUP) CEO exercises RSUs and sells 491 shares
Trupanion CEO Margaret Tooth engaged in a mix of stock transactions, including an open-market sale of 491 common shares at $21.86 each and the conversion of 19,042 restricted stock units (RSUs) into common stock. The transactions, detailed in a Form 4 filing, also involved the withholding of 6,999 shares by the company to cover tax obligations, which were not considered sales by the CEO. Following these activities, Tooth holds 176,379 shares of Trupanion common stock, with the filing also correcting a previous administrative error in beneficial ownership reporting.
